glucagon like peptide 1 glp 1 Glucagon-like 1, Glucose-Dependent Insulinotropic Polypeptide, and Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Pharmacogenetics of Glucagon-like-peptide-1 receptor in
Description
GLP-1RAs have been shown to exert a protective factor by reducing stroke (RR 0.84
Clinical trials use it as enrollment criteria
Neuropsychopharmacology 42, 216241
Regulatory and Clinical Support : Guidelines recognizing obesity as a chronic disease and broader approval of GLP1 drugs are pushing adoption and reimbursement in healthcare systems
From bench to bedside
